Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 213-934-0 | CAS number: 1067-53-4
Endpoint summary
Administrative data
Description of key information
In the key acute oral toxicity study (WIL, 1999a), the LD50 for rats was determined to be >2000 mg/kg in a study that was carried out in accordance with OECD 401 and in compliance with GLP. A majority of the rats were noted with various discoloured areas due to discharges/excretions. Other findings in approximately one-third of the animals included abnormal excretion, hypoactivity and tremors. One male and one female died at the 2000 mg/kg dose level. Gastrointestinal abonormalities were detected at necropsy of one of the animals that died.
In the key acute dermal toxicity study (WIL, 1999b), the LD50 for rats was determined to be >2000 mg/kg in a study that was carried out in accordance with OECD 402 and in compliance with GLP. There were no clinical signs of toxicity or abormalities at necropsy, although local desquamation was observed.
Key value for chemical safety assessment
Additional information
The key acute oral and dermal studies were selected as the only available data for these endpoints that followed OECD test guidelines and were in compliance with GLP, and hence were assigned Reliability 2 (WIL, 1999a and WIL, 1999b). Two additional acute oral toxicity studies in rats were assigned Reliability 2 since they were not GLP and pre-dated the OECD guidelines. The LD50 was determined to be >2000 mg/kg in all cases.
A second acute dermal toxicity study in rabbits is available (Mellon, 1954), which gave an LD50 of ca. 1.5 ml/kg (equivalent to ca. 1545 mg/kg based on a density of 1.03 g/cm3). However, the more recent guideline study is used for classification purposes because the older study used occlusive coverings that resulted in necrosis of the skin, so subsequent deaths and other effects may have been secondary to corrosion.
Justification for classification or non-classification
On the basis of reliable data for the oral and dermal routes, tris(2 -methoxyethoxy)vinylsilane is not classified for acute toxicity according to EU Directive 67/548/EEC and Regulation 1272/2008.
No reliable data are available for the inhalation route.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Route: .live2